COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey
ObjectivesThe COVID-19 pandemic imposed an enormous disease and economic burden worldwide. SARS-CoV-2 vaccination is essential to containing the pandemic. People living with HIV (PLWH) may be more vulnerable to severe COVID-19 outcomes; thus, understanding their vaccination willingness and influenci...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1322440/full |
| _version_ | 1827378631270203392 |
|---|---|
| author | Xihong Zhang Haoting Zhan Lijing Wang Yongmei Liu Xinru Guo Chen Li Xiaomeng Li Xiaomeng Li Beilei Li Haolong Li Yingxia Li Qian Chen Huixia Gao Fumin Feng Yongzhe Li Yongzhe Li Erhei Dai |
| author_facet | Xihong Zhang Haoting Zhan Lijing Wang Yongmei Liu Xinru Guo Chen Li Xiaomeng Li Xiaomeng Li Beilei Li Haolong Li Yingxia Li Qian Chen Huixia Gao Fumin Feng Yongzhe Li Yongzhe Li Erhei Dai |
| author_sort | Xihong Zhang |
| collection | DOAJ |
| description | ObjectivesThe COVID-19 pandemic imposed an enormous disease and economic burden worldwide. SARS-CoV-2 vaccination is essential to containing the pandemic. People living with HIV (PLWH) may be more vulnerable to severe COVID-19 outcomes; thus, understanding their vaccination willingness and influencing factors is helpful in developing targeted vaccination strategies.MethodsA cross-sectional study was conducted between 15 June and 30 August 2022 in Shijiazhuang, China. Variables included socio-demographic characteristics, health status characteristics, HIV-related characteristics, knowledge, and attitudes toward COVID-19 vaccination and COVID-19 vaccination status. Multivariable logistic regression was used to confirm factors associated with COVID-19 vaccination willingness among PLWH.ResultsA total of 1,428 PLWH were included, with a 90.48% willingness to receive the COVID-19 vaccination. PLWH were more unwilling to receive COVID-19 vaccination for those who were female or had a fair/poor health status, had an allergic history and comorbidities, were unconvinced and unsure about the effectiveness of vaccines, were unconvinced and unsure about the safety of vaccines, were convinced and unsure about whether COVID-19 vaccination would affect ART efficacy, or did not know at least a type of domestic COVID-19 vaccine. Approximately 93.00% of PLWH have received at least one dose of the COVID-19 vaccine among PLWH, and 213 PLWH (14.92%) reported at least one adverse reaction within 7 days.ConclusionIn conclusion, our study reported a relatively high willingness to receive the COVID-19 vaccination among PLWH in Shijiazhuang. However, a small number of PLWH still held hesitancy; thus, more tailored policies or guidelines from the government should be performed to enhance the COVID-19 vaccination rate among PLWH. |
| first_indexed | 2024-03-08T12:58:44Z |
| format | Article |
| id | doaj.art-dc9b4998015e4e748cbd9f272ddc3228 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-08T12:58:44Z |
| publishDate | 2024-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-dc9b4998015e4e748cbd9f272ddc32282024-01-19T13:05:52ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-01-011110.3389/fmed.2024.13224401322440COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional surveyXihong Zhang0Haoting Zhan1Lijing Wang2Yongmei Liu3Xinru Guo4Chen Li5Xiaomeng Li6Xiaomeng Li7Beilei Li8Haolong Li9Yingxia Li10Qian Chen11Huixia Gao12Fumin Feng13Yongzhe Li14Yongzhe Li15Erhei Dai16Center for Disease Control and Prevention of Yunyan District in Guiyang, Guiyang, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of AIDS, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaSchool of Public Health, North China University of Science and Technology, Tangshan, ChinaDepartment of AIDS, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of AIDS, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of AIDS, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaDepartment of AIDS, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaHebei Key Laboratory of Immune Mechanism of Major Infectious Diseases and New Technology of Diagnosis and Treatment, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaSchool of Public Health, North China University of Science and Technology, Tangshan, ChinaDepartment of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, ChinaHebei Key Laboratory of Immune Mechanism of Major Infectious Diseases and New Technology of Diagnosis and Treatment, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, ChinaObjectivesThe COVID-19 pandemic imposed an enormous disease and economic burden worldwide. SARS-CoV-2 vaccination is essential to containing the pandemic. People living with HIV (PLWH) may be more vulnerable to severe COVID-19 outcomes; thus, understanding their vaccination willingness and influencing factors is helpful in developing targeted vaccination strategies.MethodsA cross-sectional study was conducted between 15 June and 30 August 2022 in Shijiazhuang, China. Variables included socio-demographic characteristics, health status characteristics, HIV-related characteristics, knowledge, and attitudes toward COVID-19 vaccination and COVID-19 vaccination status. Multivariable logistic regression was used to confirm factors associated with COVID-19 vaccination willingness among PLWH.ResultsA total of 1,428 PLWH were included, with a 90.48% willingness to receive the COVID-19 vaccination. PLWH were more unwilling to receive COVID-19 vaccination for those who were female or had a fair/poor health status, had an allergic history and comorbidities, were unconvinced and unsure about the effectiveness of vaccines, were unconvinced and unsure about the safety of vaccines, were convinced and unsure about whether COVID-19 vaccination would affect ART efficacy, or did not know at least a type of domestic COVID-19 vaccine. Approximately 93.00% of PLWH have received at least one dose of the COVID-19 vaccine among PLWH, and 213 PLWH (14.92%) reported at least one adverse reaction within 7 days.ConclusionIn conclusion, our study reported a relatively high willingness to receive the COVID-19 vaccination among PLWH in Shijiazhuang. However, a small number of PLWH still held hesitancy; thus, more tailored policies or guidelines from the government should be performed to enhance the COVID-19 vaccination rate among PLWH.https://www.frontiersin.org/articles/10.3389/fmed.2024.1322440/fullpeople living with HIVCOVID-19vaccinewillingnessinfluencing factors |
| spellingShingle | Xihong Zhang Haoting Zhan Lijing Wang Yongmei Liu Xinru Guo Chen Li Xiaomeng Li Xiaomeng Li Beilei Li Haolong Li Yingxia Li Qian Chen Huixia Gao Fumin Feng Yongzhe Li Yongzhe Li Erhei Dai COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey Frontiers in Medicine people living with HIV COVID-19 vaccine willingness influencing factors |
| title | COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey |
| title_full | COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey |
| title_fullStr | COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey |
| title_full_unstemmed | COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey |
| title_short | COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey |
| title_sort | covid 19 vaccination willingness among people living with hiv in shijiazhuang china a cross sectional survey |
| topic | people living with HIV COVID-19 vaccine willingness influencing factors |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2024.1322440/full |
| work_keys_str_mv | AT xihongzhang covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT haotingzhan covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT lijingwang covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT yongmeiliu covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT xinruguo covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT chenli covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT xiaomengli covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT xiaomengli covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT beileili covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT haolongli covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT yingxiali covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT qianchen covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT huixiagao covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT fuminfeng covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT yongzheli covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT yongzheli covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey AT erheidai covid19vaccinationwillingnessamongpeoplelivingwithhivinshijiazhuangchinaacrosssectionalsurvey |